Xuezhikang Therapy Increases miR-33 Expression in Patients with Low HDL-C Levels

Table 1

Baseline patient characteristics.

Characteristics	𝑁=40
Age, y	58.7 ± 10.6
Male gender, number (%)	10 (25)
BMI, kg/m^2	28.1 ± 4.8
SBP, mm Hg	138 ± 15
DBP, mm Hg	87 ± 9
TC, mmol/L	5.54 ± 0.76
TG, mmol/L^†	2.85 (2.16, 3.97)
HDL-C, mmol/L	1.07 ± 0.13
LDL-C, mmol/L	3.35 ± 0.72
Fasting glucose, mmol/L	5.4 ± 1.7
Hypertension, number (%)	24 (60)

Age, body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), total plasma cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and fasting glucose values are given as mean ± standard deviation.
^†Triglycerides (TG), values as median (quartile 1, quartile 3).